Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The controversies of parabens – an overview nowadays (CROSBI ID 287698)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Petric, Zvonimir ; Ružić, Julija ; Žuntar, Irena The controversies of parabens – an overview nowadays // Acta pharmaceutica, 71 (2021), 1; 17-32. doi: 10.2478/acph-2021-0001

Podaci o odgovornosti

Petric, Zvonimir ; Ružić, Julija ; Žuntar, Irena

engleski

The controversies of parabens – an overview nowadays

Effects of paraben toxicity, i.e., endocrine- disruption properties, are in the focus of researchers for decades, but still – they are a hot subject of debate. Parabens are aliphatic esters of p-hydroxybenzoic acid, which are widely used as antimicrobial agents for the preservation of cosmetics, pharmaceuticals and foods. Mostly used parabens are methyl-, ethyl-, propyl- and butylparaben. Although the toxicity of parabens is reported in animals and in in vitro studies, it cannot be taken for granted when discussing hazards for human health due to an unrealistic exposure-safety profile. Many studies have demonstrated that parabens are non-teratogenic, non-mutagenic, non-carcinogenic and the real evidence for their toxicity in humans has not been established. For now, methyl-, ethyl- and propylparaben are considered safe for use in cosmetics and pharmaceuticals within the recommended range of doses. Regarding alternatives for parabens, a variety of approaches have been proposed, but every substitute would need to be tested rigorously for toxicity and safety.

parabeni ; toksičnost ; endokrina disrupcija ; zdravstveni rizik

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

71 (1)

2021.

17-32

objavljeno

1330-0075

1846-9558

10.2478/acph-2021-0001

Povezanost rada

Farmacija, Javno zdravstvo i zdravstvena zaštita

Poveznice
Indeksiranost